KANAMYCIN IN THE TREATMENT OF INFECTIONS IN INFANTS AND CHILDREN

doi:10.1111/j.1749-6632.1958.tb54719.x

Paper

KANAMYCIN IN THE TREATMENT OF INFECTIONS IN INFANTS AND CHILDREN

Published Sep 1, 1958 · R. High, Antonio Sarria, N. Huang

Annals of the New York Academy of Sciences

Q1 SJR score

15

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Kanamycin sulfate, originally isolated and studied by Umezawa and his associates at the Japanese National Institute of Health and at Tokyo University, has wide antimicrobial Preliminary studies in the United States have confirmed this finding as reported in February 1958.6 The present study was undertaken to obtain preliminary information on the use of this drug in infants and children. Certain bacteriological studies were made on freshly isolated bacterial species. Serum concentrations of the drug were analyzed following a variety of intramuscular doses of kanamycin sulfate. Finally, a group of infants and children was treated with this new antimicrobial drug The results of these studies are reported below.

Observational Study

Study Snapshot

Kanamycin sulfate shows promising antimicrobial activity in infants and children, with potential for use in treating infections.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

KANAMYCIN IN THE TREATMENT OF INFECTIONS IN INFANTS AND CHILDREN

Sign up to use Study Snapshot

References

Citations